Videos

Key Paper Webinar: the LAPPRO trial

Are some surgeons better than others? Anders Bjartell, John Yaxley & the BJUI team discuss surgeon heterogeneity in the Swedish LAPPRO study published in the BJUI March 2021.     Read the paper here: bjui.pub/BJUI-LAPPRO        

Video: Modifiable lifestyle behaviours impact the health‐related quality of life of bladder cancer survivors

Modifiable lifestyle behaviours impact the health‐related quality of life of bladder cancer survivors Abstract Objective To examine health behaviours in bladder cancer survivors including physical activity (PA), body mass index, diet quality, smoking and alcohol consumption, and to explore their relationship with health‐related quality of life (HRQoL). Subjects/Patients and Methods Cross‐sectional questionnaire packages were distributed to bladder cancer survivors (muscle‐invasive…

Video: Efficacy of vibegron, a novel β3‐adrenoreceptor agonist, on severe urgency urinary incontinence related to overactive bladder

Efficacy of vibegron, a novel β3‐adrenoreceptor agonist, on severe urgency urinary incontinence related to overactive bladder: post hoc analysis of a randomized, placebo‐controlled, double‐blind, comparative phase 3 study Abstract Objective To evaluate the efficacy of a novel and selective β3‐adrenoreceptor agonist vibegron on urgency urinary incontinence (UUI) in patients with overactive bladder (OAB). Patients and Methods A post hoc analysis was…

Video: Prostate cancer in kidney transplant recipients – a nationwide register study

: Prostate cancer in kidney transplant recipients – a nationwide register study Abstract Objective To investigate whether post‐transplantation immunosuppression negatively affects prostate cancer outcomes in male kidney transplant recipients. Patients and Methods We used the Swedish Renal Register and the National Prostate Cancer Register to identify all kidney transplantation recipients diagnosed with prostate cancer in Sweden 1998–2016. After linking these registers with…
© 2024 BJU International. All Rights Reserved.